Antitumor effects of an immunotoxin made with Pseudomonas exotoxin in a nude mouse model of human ovarian cancer.
- 1 September 1986
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 83 (17) , 6627-6630
- https://doi.org/10.1073/pnas.83.17.6627
Abstract
An immunotoxin composed of Pseudomonas toxin coupled to an antibody to the human transferrin receptor was evaluated for its effect on ovarian cancer. In the tumor model employed, 60 million human ovarian cancer cells were injected into the peritoneal cavity of an immunodeficient nude mouse. By day 5, cancer cells were implanted and growing in smaller clusters throughout the peritoneal cavity. On day 5-8, 0.3-2 .mu.g of immunotoxin was injected into the peritoneal cavity. Control mice died with malignant ascites at 34-58 days after the implantation of tumor cells, whereas immunotoxin-treated mice lived to 100 days or longer. Irrelevant immunotoxins or antibody alone had no antitumor activity. These findings suggest that intraperitoneal injection of immunotoxins may have a role in the treatment of ovarian cancer.This publication has 22 references indexed in Scilit:
- Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry.Journal of Biological Chemistry, 1986
- Isolation and characterization of a highly enriched preparation of receptosomes (endosomes) from a human cell line.Proceedings of the National Academy of Sciences, 1983
- Transferrin receptors in human tissues: their distribution and possible clinical relevance.Journal of Clinical Pathology, 1983
- Immunotoxins: A New Approach to Cancer TherapyScience, 1983
- GUINEA-PIG LINE 10 HEPATO-CARCINOMA MODEL - CHARACTERIZATION OF MONOCLONAL-ANTIBODY AND INVIVO EFFECT OF UNCONJUGATED ANTIBODY AND ANTIBODY CONJUGATED TO DIPHTHERIA TOXIN-A CHAIN1983
- Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth.Proceedings of the National Academy of Sciences, 1983
- Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution.Journal of Biological Chemistry, 1982
- Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cellsNature, 1981
- Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.The Journal of Immunology, 1981
- TRANSFERRIN AND TRANSFERRIN RECEPTORS IN CARCINOMA OF THE BREASTThe Lancet, 1980